Artificial Intelligence in Healthcare Market Size, Share, Industry Trends and Forecast 2024-2032

The latest report by IMARC Group, titled “Artificial Intelligence in Healthcare Market Report by Offering (Hardware, Software, Services), Technology (Machine Learning, Context Aware Computing, Natural Language Processing, and Others), Application (Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, and Others), End-User (Healthcare Providers, Pharmaceutical and Biotechnology Companies, Patients, and Others), and Region 2024-2032“, offers a comprehensive analysis of the industry, which comprises insights on the global artificial intelligence in healthcare market share. The global market size reached US$ 6.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 57.2 Billion by 2032, exhibiting a growth rate (CAGR) of 27.4% during 2024-2032.

Factors Affecting the Growth of the Artificial Intelligence in the Healthcare Industry:

  • Technological Advancements:

The field of healthcare is experiencing transformative changes due to continued advancements in AI algorithms, machine learning models, and computing power. These technological strides are enhancing the accuracy of diagnostics, allowing for earlier and more precise detection of diseases such as cancer and cardiovascular conditions. Furthermore, the ability of AI to analyze vast datasets enables the development of personalized treatment plans tailored to individual genetic profiles, lifestyle factors, and medical histories, ensuring that treatments are effective and minimize side effects. Besides this, AI technologies streamline healthcare operations by optimizing hospital workflow, reducing wait times, and improving patient care management. Along with this, the integration of advanced technology elevates patient outcomes and assists healthcare providers in managing the increasing complexity of medical diagnostics and treatments across the globe.

  • Rise of Telehealth and Remote Monitoring:

The COVID-19 pandemic catalyzed the rapid adoption of telehealth and remote monitoring technologies. This shift has significantly expanded the scope for AI-driven solutions in healthcare. Additionally, AI enhances telehealth services by enabling real-time data analysis, which assists in monitoring chronic conditions and conducting routine follow-ups without the need for physical office visits. Moreover, remote monitoring tools, integrated with AI, can predict patient deterioration and alert healthcare providers before the condition worsens, thereby improving response times and potentially saving lives. Besides this, AI’s role in virtual care platforms also extends to symptom assessment tools, personalized health coaching, and managing patient data across numerous platforms. These innovations make healthcare more accessible and ensure continuous support and care management, thus contributing to market growth.

  • Increasing Investment and Funding:

There is a significant upsurge in investment and funding for AI in healthcare from various stakeholders, including venture capitalists, established healthcare organizations, and tech giants. Additionally, this financial support is driving the research, development, and implementation of advanced AI technologies within the healthcare sector. Moreover, several investors are particularly interested in AI applications that promise to reduce costs, improve operational efficiency, and deliver superior patient outcomes. As a result, startups and established companies are exploring innovative AI solutions that range from robotic surgical assistants to AI-driven diagnostic systems. Hence, the influx of capital is fostering a competitive market environment and speeding up the pace of innovation, ensuring that AI continues to transform the way healthcare services are delivered and managed, making them more effective and patient-centric across the globe.

Competitive Landscape with Key Player:

  • Amazon Web Services Inc.
  • Cloudmedx Inc.
  • DeepMind
  • Enlitic Inc.
  • General Vision Inc.
  • Google Inc.
  • International Business Machines
  • iCarbonX
  • Intel Corporation
  • Medtronic
  • Micron Technology Inc.
  • Microsoft Corporation
  • Next It Corporation
  • Nuance Communications Inc.
  • Nvidia Corporation
  • Siemens Healthcare
  • Welltok Inc.

For an in-depth analysis, you can refer sample copy of the report:

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Offering:

  • Hardware
  • Software
  • Services

Software represents the largest segment due to its versatility in managing patient data, optimizing operations, and facilitating decision-making processes in healthcare settings.

Breakup by Technology:

  • Machine Learning
  • Context-Aware Computing
  • Natural Language Processing
  • Others

Machine learning holds the largest market share due to its ability to analyze vast amounts of medical data, improve diagnostic accuracy, and personalize treatment plans.

Breakup by Application:

  • Robot-Assisted Surgery
  • Virtual Nursing Assistant
  • Administrative Workflow Assistance
  • Fraud Detection
  • Dosage Error Reduction
  • Clinical Trial Participant Identifier
  • Preliminary Diagnosis
  • Others

Clinical trial participant identifiers dominate the market growth as they are crucial for ensuring accurate participant tracking, compliance with regulatory standards, and data integrity in clinical research.

Breakup by End-User:

  • Healthcare Providers
  • Pharmaceutical and Biotechnology Companies
  • Patients
  • Others

Pharmaceutical and biotechnology companies account for the largest market share due to their extensive use of AI technologies for drug discovery, development, and optimizing manufacturing processes.

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America’s dominance in artificial intelligence in the healthcare market is attributed to its advanced healthcare infrastructure, early adoption of AI technologies, significant investments in research and development, and supportive regulatory environment.

Global Artificial Intelligence in the Healthcare Market Trends:

At present, AI is revolutionizing medical imaging interpretation and diagnostics. Machine learning algorithms can analyze images like MRI, and CT scans, with high accuracy, aiding in early detection and diagnosis of diseases. Moreover, AI enables the creation of personalized treatment plans by analyzing vast amounts of patient data, including genetic information, medical records, and lifestyle factors. This can lead to more effective and tailored healthcare interventions. Besides this, AI-powered virtual health assistants and chatbots are widely employed for patient engagement, providing information, scheduling appointments, and even offering basic medical advice

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US


134 N 4th St. Brooklyn, NY 11249, USA


Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145